TickerFacts.

A business in context

DHR research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-21 · 0000313616-26-000187

  2. 4 · Ownership change

    Report date 2026-08-04 · 0001193125-26-338380

  3. 4 · Ownership change

    Report date 2026-08-04 · 0001193125-26-338379

  4. 4 · Ownership change

    Report date 2026-08-04 · 0000313616-26-000185

  5. 4 · Ownership change

    Report date 2026-08-04 · 0000313616-26-000184

  6. 4 · Ownership change

    Report date 2026-08-04 · 0000313616-26-000183

  7. 4 · Ownership change

    Report date 2026-08-04 · 0000313616-26-000182

  8. 4 · Ownership change

    Report date 2026-08-04 · 0000313616-26-000181

  9. 8-K · Current report

    Report date 2026-07-31 · 0001193125-26-330652 · Items 5.02,7.01,8.01,9.01

  10. 8-K · Current report

    Report date 2026-07-21 · 0000313616-26-000163 · Items 2.02,9.01

  11. 10-Q · Quarterly report

    Report date 2026-06-26 · 0000313616-26-000161

  12. 8-K · Current report

    Report date 2026-06-03 · 0001193125-26-255555 · Items 2.03,8.01

  13. 8-K · Current report

    Report date 2026-05-05 · 0000313616-26-000127 · Items 5.02,5.07,9.01

  14. 8-K · Current report

    Report date 2026-04-22 · 0001193125-26-191608 · Items 1.01,8.01,9.01

  15. 8-K · Current report

    Report date 2026-04-21 · 0000313616-26-000109 · Items 2.02,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-27 · 0000313616-26-000107

  17. 8-K · Current report

    Report date 2026-04-16 · 0001193125-26-160383 · Items 1.01,2.03,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-05-05 · 0000313616-26-000101

  19. 10-K · Annual report

    Report date 2025-12-31 · 0000313616-26-000062

  20. 8-K · Current report

    Report date 2026-02-16 · 0001193125-26-053124 · Items 8.01,9.01

  21. 8-K · Current report

    Report date 2026-02-05 · 0000313616-26-000058 · Items 5.02,9.01

  22. 8-K · Current report

    Report date 2026-01-28 · 0000313616-26-000004 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2026-01-12 · 0000313616-26-000002 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-11-06 · 0000313616-25-000198 · Items 5.02,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-26 · 0000313616-25-000182

  26. 8-K · Current report

    Report date 2025-10-21 · 0000313616-25-000180 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-09-09 · 0000313616-25-000178 · Items 5.03,8.01,9.01

  28. 8-K · Current report

    Report date 2025-07-28 · 0000313616-25-000172 · Items 5.02,9.01

  29. 8-K · Current report

    Report date 2025-07-21 · 0000313616-25-000155 · Items 5.02,9.01

  30. 10-Q · Quarterly report

    Report date 2025-06-27 · 0000313616-25-000153

  31. 8-K · Current report

    Report date 2025-07-22 · 0000313616-25-000152 · Items 2.02,9.01

  32. 8-K · Current report

    Report date 2025-05-06 · 0000313616-25-000110 · Items 5.07,9.01

  33. 8-K · Current report

    Report date 2025-04-22 · 0000313616-25-000090 · Items 2.02,9.01

  34. 10-Q · Quarterly report

    Report date 2025-03-28 · 0000313616-25-000088

  35. DEF 14A · Proxy statement

    Report date 2025-05-06 · 0000313616-25-000081

  36. 8-K · Current report

    Report date 2025-02-20 · 0000313616-25-000044 · Items 5.02,9.01

  37. 10-K · Annual report

    Report date 2024-12-31 · 0000313616-25-000043

  38. 8-K · Current report

    Report date 2025-01-29 · 0000313616-25-000004 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-01-13 · 0000313616-25-000002 · Items 2.02,9.01

  40. 8-K · Current report

    Report date 2024-12-09 · 0000313616-24-000251 · Items 5.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 23 transaction rows23AExercise / conversion: 2 transaction rows2MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

27 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-15
2026-05-19
FILLER LINDAA · Grant / award
Acquired
Common Stock680.00.0
2026-05-15
2026-05-19
FILLER LINDAA · Grant / award
Acquired
Director stock option (right to buy)
Derivative security
1699.00.0
2026-05-15
2026-05-19
Couchara GeorgeannF · Tax / exercise payment
Disposed
Common Stock281.0161.91
2026-05-15
2026-05-19
Stevens Raymond CA · Grant / award
Acquired
Common Stock680.00.0
2026-05-15
2026-05-19
Stevens Raymond CA · Grant / award
Acquired
Director stock option (right to buy)
Derivative security
1699.00.0
2026-05-15
2026-05-19
SPOON ALAN GA · Grant / award
Acquired
Common Stock680.00.0
2026-05-15
2026-05-19
SPOON ALAN GA · Grant / award
Acquired
Director stock option (right to buy)
Derivative security
1699.00.0
2026-05-15
2026-05-19
Sanders A ShaneA · Grant / award
Acquired
Common Stock680.00.0
2026-05-15
2026-05-19
Sanders A ShaneA · Grant / award
Acquired
Director stock option (right to buy)
Derivative security
1699.00.0
2026-05-15
2026-05-19
List TeriA · Grant / award
Acquired
Common Stock680.00.0
2026-05-15
2026-05-19
List TeriA · Grant / award
Acquired
Director stock option (right to buy)
Derivative security
1699.00.0
2026-05-15
2026-05-19
Zerhouni Elias A.A · Grant / award
Acquired
Common Stock680.00.0
2026-05-15
2026-05-19
Zerhouni Elias A.A · Grant / award
Acquired
Director stock option (right to buy)
Derivative security
1699.00.0
2026-05-15
2026-05-19
Dewan FerozA · Grant / award
Acquired
Common Stock680.00.0
2026-05-15
2026-05-19
Dewan FerozA · Grant / award
Acquired
Director stock option (right to buy)
Derivative security
1699.00.0
2026-05-15
2026-05-19
Lamanna Charles WA · Grant / award
Acquired
Common Stock680.00.0
2026-05-15
2026-05-19
Lamanna Charles WA · Grant / award
Acquired
Director stock option (right to buy)
Derivative security
1699.00.0
2026-05-01
2026-05-04
SPOON ALAN GM · Exercise / conversion
Acquired
Common Stock3298.071.88
2026-05-01
2026-05-04
SPOON ALAN GS · Sale
Disposed
Common Stock1358.0174.67
2026-05-01
2026-05-04
SPOON ALAN GM · Exercise / conversion
Disposed
Director stock option (right to buy)
Derivative security
3298.00.0
2026-04-24
2026-04-28
Stevens Raymond CA · Grant / award
Acquired
Phantom shares
Derivative security
199.26177.25
2026-04-24
2026-04-28
Sanders A ShaneA · Grant / award
Acquired
Phantom shares
Derivative security
231.81177.25
2026-04-24
2026-04-28
List TeriA · Grant / award
Acquired
Phantom shares
Derivative security
17.25177.25
2026-04-24
2026-04-28
Zerhouni Elias A.A · Grant / award
Acquired
Phantom shares
Derivative security
259.72177.25
2026-04-24
2026-04-28
FILLER LINDAA · Grant / award
Acquired
Phantom shares
Derivative security
20.12177.25
2026-04-24
2026-04-28
SPOON ALAN GA · Grant / award
Acquired
Phantom shares
Derivative security
252.32177.25
2026-04-24
2026-04-28
Dewan FerozA · Grant / award
Acquired
Phantom shares
Derivative security
187.89177.25

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000313616DANAHER CORP /DE/
Danaher (United Kingdom)Danaher (China)Danaher (Australia)Danaher (Sweden)Danaher (Germany)Danaher (Singapore)Danaher (Switzerland)Beckman CoulterNobel BiocareIntegrated DNA Technologies

Showing 10 of 10 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
S4BKK9OTCEWQ3YHPFM11
GLEIF legal name
DANAHER CORPORATION
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2025-12-26T05:35:40Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Danaher Corporation · alias · wikidata
  • Danaher · alias · wikidata
  • Danaher (United Kingdom) · subsidiary · wikidata
  • Danaher (China) · subsidiary · wikidata
  • Danaher (Australia) · subsidiary · wikidata
  • Danaher (Sweden) · subsidiary · wikidata
  • Danaher (Germany) · subsidiary · wikidata
  • Danaher (Singapore) · subsidiary · wikidata
  • Danaher (Switzerland) · subsidiary · wikidata
  • Beckman Coulter · subsidiary · wikidata
  • Beckman Instruments · subsidiary · wikidata
  • Beckman Instruments, Inc. · subsidiary · wikidata
  • Nobel Biocare · subsidiary · wikidata
  • Integrated DNA Technologies · subsidiary · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$23.88B$25.41B
2023-12-31$23.89B$26.18B
2022-12-31$26.64B$30.39B
2021-12-31$24.80B$30.56B
2020-12-31$22.28B$28.75B
2019-12-31$17.91B$23.39B
2018-12-31$17.05B$22.67B
2017-12-31$15.52B$21.14B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗